ABT Financial Facts
Total Operating Cost and Expenses: 4.76BBasic Earnings Per Common Share (in dollars per share): 0.35
See Full Income Statement
Current portion of long-term debt: 277.6M
Earnings employed in the business: 20.06B
See Full Balance Sheet
Earnings History for Abbott Labs (ABT)
|
Expand Research on ABT
| Next EPS Date | 7/17/13 *Est. | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +1.4% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -2.4% |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Estimize EPS/Revs | Gd. | % Since | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
1/23/13  |
 |
Q412 | $1.51 | $1.50 | +$0.01 | $10.8B | $10.58B | N/A / N/A | = | +11.2% | Details |
| 1/25/12 |
|
Q411 | $1.45 | $1.44 | +$0.01 | $10.4B | $10.63B | $1.44 / $10.68B | = | -34.6% | Details |
| 1/26/11 |
|
Q410 | $1.30 | $1.29 | +$0.01 | $9.97B | $9.89B | N/A / N/A | = | -23.7% | Details |
| 10/19/11 |
|
Q311 | $1.18 | $1.17 | +$0.01 | $9.82B | $9.65B | N/A / N/A | = | -30.2% | Details |
| 7/18/12 |
|
Q212 | $1.23 | $1.22 | +$0.01 | $9.81B | $9.84B | $1.23 / $9.92B | = | -44.9% | Details |
| 10/17/12 |
|
Q312 | $1.30 | $1.28 | +$0.02 | $9.77B | $9.93B | $1.30 / $9.95B | = | -49.3% | Details |
| 7/20/11 |
|
Q211 | $1.12 | $1.11 | +$0.01 | $9.62B | $9.56B | N/A / N/A | = | -30.8% | Details |
| 4/18/12 |
|
Q411 | $1.03 | $0.99 | +$0.04 | $9.46B | $9.35B | $1.44 / $10.68B | = | -39.5% | Details |
